New Technology Submission Portal

Partner with us

Our New Technology review process is designed to bring together decision-makers from Product Management, Engineering, Regulatory and Intellectual Property to assess each submission and provide feedback in a responsive and transparent manner.  If you have a practical solution to an unmet clinical need, we would love to hear from you.

Tech1
Tech2
Tech3
Tech4

At this time, we ask that you only submit non-confidential information in order for us to determine if there is alignment within our core areas of procedural spine solutions or specialized orthopedics.   Your submission must have enough information to allow it to be directed to the proper business leaders for an initial assessment.  Once your submission has been reviewed and logged, you will receive an email that your submission has been successfully received. 

Once received, your submission will be reviewed by one of our New Technology Committees. These committees are comprised of cross-functional business leaders that will look at your ideas in the context of commercialization, intellectual property, technical feasibility, and alignment with our corporate strategy.  You will be contacted at the end of this process. 

After approval by the New Technology Committee, a deeper assessment of your ideas will take place.  At this time, a Non-Disclosure Agreement (NDA) may be needed so that confidential information may be shared.  In this stage our Marketing Team will look at the business case for commercializing the product.  Our Development Team may perform prototyping or feasibility testing.  Our Legal Team will look at the IP landscape surrounding your idea.

Once your idea has met the requirements established by the business leads, a framework for our partnership will be established.  Once completed, it will be presented to our Global Executive Committee for final approval. 

Non-Confidential Information Disclosure

NuVasive’s New Technology review process begins with an initial assessment of non-confidential information.  Once NuVasive determines that there may be a mutually beneficial opportunity, the parties may enter into a Non-Disclosure Agreement (“NDA”). However, any and all information provided to NuVasive at this stage and/or via this portal shall be considered non-confidential information and NuVasive shall be under no obligations to treat any such information as confidential and/or proprietary as to the submitting entity/individual. 

Privacy Statement

Your privacy is important to NuVasive. We employ procedural and technological security measures that are reasonably designed to help protect your personally identifiable information from loss, unauthorized access, disclosure, alteration or destruction.

We may provide your personal information to our parent, subsidiary and affiliate entities within our corporate family.

Please be aware that your personal data may also reside on servers in other countries. Your data may be transferred to the United States and other countries, which may not offer an equivalent level of protection as that in your country. If you are from the European Union, note that NuVasive uses contractual measures to ensure that an adequate level of data protection is provided according to local standards.

NuVasive respects your right to access and correct your personal information. You may request to review, correct, update, or delete your personal information at any time by contacting us via email at [email protected]asive.com.